Cargando…
Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling
Chemotherapy for suppressing tumor growth and metastasis tends to induce various effects on other organs. Using AZD7762, an inhibitor of checkpoint kinase (Chk) 1 and 2, the present study examined its effect on mammary tumor cells in addition to bone cells (osteoclasts, osteoblasts and osteocytes),...
Autores principales: | Wang, Luqi, Wang, Yue, Chen, Andy, Jalali, Aydin, Liu, Shengzhi, Guo, Yunxia, Na, Sungsoo, Nakshatri, Harikrishna, Li, Bai-Yan, Yokota, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065446/ https://www.ncbi.nlm.nih.gov/pubmed/30015873 http://dx.doi.org/10.3892/ijo.2018.4481 |
Ejemplares similares
-
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
por: Isono, Makoto, et al.
Publicado: (2017) -
Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019) -
Inhibiting checkpoint kinase 1 protects bone from bone resorption by mammary tumor in a mouse model
por: Liu, Shengzhi, et al.
Publicado: (2018) -
Attraction and Compaction of Migratory Breast Cancer Cells by Bone Matrix Proteins through Tumor-Osteocyte Interactions
por: Chen, Andy, et al.
Publicado: (2018) -
Suppression of the metastatic spread of breast cancer by DN10764 (AZD7762)-mediated inhibition of AXL signaling
por: Park, Joon-Suk, et al.
Publicado: (2016)